Advertisement
Screener

OMEROS CORP (OMER) Other

OMEROS CORP Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2024-04-01: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.01 per share · OMER · NASDAQ.
  • 2023-08-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · OMER · NASDAQ.
  • 2023-05-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · OMER · NASDAQ.
  • 2023-05-01: Form 10-K/A; Item Stock registered under Section 12(b); As filed Common Stock · OMER · NASDAQ.
FiledFormItemAs filed
2024-04-0110-KStock registered under Section 12(b)Common Stock, par value $0.01 per share · OMER · NASDAQ
2023-08-0910-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2023-05-0910-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2023-05-0110-K/AStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2023-03-1310-KStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2022-11-0910-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2022-11-0910-QSmaller reporting companyNo
2022-08-0910-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2022-08-0910-QSmaller reporting companyNo
2022-05-1010-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2022-05-1010-QSmaller reporting companyNo
2022-03-0110-KStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2022-03-0110-KSmaller reporting companyNo
2021-11-0910-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2021-11-0910-QSmaller reporting companyNo
2021-08-0910-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2021-08-0910-QSmaller reporting companyNo
2021-05-1010-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2021-05-1010-QSmaller reporting companyNo
2021-03-0110-KStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2021-03-0110-KSmaller reporting companyNo
2021-03-0110-KWell-known seasoned issuerYes
2020-11-0910-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2020-11-0910-QSmaller reporting companyNo
2020-08-1010-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2020-08-1010-QSmaller reporting companyNo
2020-05-1110-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2020-05-1110-QSmaller reporting companyNo
2020-03-0210-KStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2020-03-0210-KSmaller reporting companyNo
2020-03-0210-KWell-known seasoned issuerYes
2019-11-1210-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2019-11-1210-QSmaller reporting companyNo
2019-08-0810-QStock registered under Section 12(b)Common Stock · OMER · NASDAQ
2019-08-0810-QSmaller reporting companyNo
2018-03-0110-KWell-known seasoned issuerYes
2016-03-1510-KWell-known seasoned issuerYes
2015-03-1610-KWell-known seasoned issuerYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82